Cargando…
Late-Relapsing Hepatitis after Yellow Fever
One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin levels. Laboratory tests discarded autoimmune hepa...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077229/ https://www.ncbi.nlm.nih.gov/pubmed/32079143 http://dx.doi.org/10.3390/v12020222 |
_version_ | 1783507384969199616 |
---|---|
author | Rezende, Izabela Maurício Pereira, Leonardo Soares Fradico, Jordana Rodrigues Barbosa Pascoal Xavier, Marcelo Antônio Alves, Pedro Augusto Campi-Azevedo, Ana Carolina Speziali, Elaine dos Santos, Lívia Zignago Moreira Albuquerque, Natalia Soares Penido, Indiara Santos, Tayrine Araujo Bom, Ana Paula Dinis Ano da Silva, Andrea Marques Vieira Fernandes, Camilla Bayma Calzavara, Carlos Eduardo Kroon, Erna Geessien Martins-Filho, Olindo Assis Teixeira-Carvalho, Andréa Drumond, Betânia Paiva |
author_facet | Rezende, Izabela Maurício Pereira, Leonardo Soares Fradico, Jordana Rodrigues Barbosa Pascoal Xavier, Marcelo Antônio Alves, Pedro Augusto Campi-Azevedo, Ana Carolina Speziali, Elaine dos Santos, Lívia Zignago Moreira Albuquerque, Natalia Soares Penido, Indiara Santos, Tayrine Araujo Bom, Ana Paula Dinis Ano da Silva, Andrea Marques Vieira Fernandes, Camilla Bayma Calzavara, Carlos Eduardo Kroon, Erna Geessien Martins-Filho, Olindo Assis Teixeira-Carvalho, Andréa Drumond, Betânia Paiva |
author_sort | Rezende, Izabela Maurício |
collection | PubMed |
description | One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin levels. Laboratory tests discarded autoimmune hepatitis, inflammatory or metabolic liver disease, and new infections caused by hepatotropic agents. Anti-YFV IgM, IgG and neutralizing antibodies were detected in different times, but no viremia. A liver biopsy was collected three months after YF onset and tested positive for YFV antigens and wild-type YFV-RNA (364 RNA-copies/gram/liver). Transaminases and bilirubin levels remained elevated for five months, and the arresting of symptoms persisted for six months after the acute YF onset. Several serum chemokines, cytokines, and growth factors were measured. A similar immune response profile was observed in the earlier phases of the disease, followed by more pronounced changes in the later stages, when transaminases levels returned to normal. The results indicated viral persistence in the liver and continual liver cell damage three months after YF onset and reinforced the need for extended follow-ups of YF patients. Further studies to investigate the role of possible viral persistence and the immune response causing relapsing hepatitis following YF are also necessary. |
format | Online Article Text |
id | pubmed-7077229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70772292020-03-20 Late-Relapsing Hepatitis after Yellow Fever Rezende, Izabela Maurício Pereira, Leonardo Soares Fradico, Jordana Rodrigues Barbosa Pascoal Xavier, Marcelo Antônio Alves, Pedro Augusto Campi-Azevedo, Ana Carolina Speziali, Elaine dos Santos, Lívia Zignago Moreira Albuquerque, Natalia Soares Penido, Indiara Santos, Tayrine Araujo Bom, Ana Paula Dinis Ano da Silva, Andrea Marques Vieira Fernandes, Camilla Bayma Calzavara, Carlos Eduardo Kroon, Erna Geessien Martins-Filho, Olindo Assis Teixeira-Carvalho, Andréa Drumond, Betânia Paiva Viruses Case Report One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin levels. Laboratory tests discarded autoimmune hepatitis, inflammatory or metabolic liver disease, and new infections caused by hepatotropic agents. Anti-YFV IgM, IgG and neutralizing antibodies were detected in different times, but no viremia. A liver biopsy was collected three months after YF onset and tested positive for YFV antigens and wild-type YFV-RNA (364 RNA-copies/gram/liver). Transaminases and bilirubin levels remained elevated for five months, and the arresting of symptoms persisted for six months after the acute YF onset. Several serum chemokines, cytokines, and growth factors were measured. A similar immune response profile was observed in the earlier phases of the disease, followed by more pronounced changes in the later stages, when transaminases levels returned to normal. The results indicated viral persistence in the liver and continual liver cell damage three months after YF onset and reinforced the need for extended follow-ups of YF patients. Further studies to investigate the role of possible viral persistence and the immune response causing relapsing hepatitis following YF are also necessary. MDPI 2020-02-17 /pmc/articles/PMC7077229/ /pubmed/32079143 http://dx.doi.org/10.3390/v12020222 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Rezende, Izabela Maurício Pereira, Leonardo Soares Fradico, Jordana Rodrigues Barbosa Pascoal Xavier, Marcelo Antônio Alves, Pedro Augusto Campi-Azevedo, Ana Carolina Speziali, Elaine dos Santos, Lívia Zignago Moreira Albuquerque, Natalia Soares Penido, Indiara Santos, Tayrine Araujo Bom, Ana Paula Dinis Ano da Silva, Andrea Marques Vieira Fernandes, Camilla Bayma Calzavara, Carlos Eduardo Kroon, Erna Geessien Martins-Filho, Olindo Assis Teixeira-Carvalho, Andréa Drumond, Betânia Paiva Late-Relapsing Hepatitis after Yellow Fever |
title | Late-Relapsing Hepatitis after Yellow Fever |
title_full | Late-Relapsing Hepatitis after Yellow Fever |
title_fullStr | Late-Relapsing Hepatitis after Yellow Fever |
title_full_unstemmed | Late-Relapsing Hepatitis after Yellow Fever |
title_short | Late-Relapsing Hepatitis after Yellow Fever |
title_sort | late-relapsing hepatitis after yellow fever |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077229/ https://www.ncbi.nlm.nih.gov/pubmed/32079143 http://dx.doi.org/10.3390/v12020222 |
work_keys_str_mv | AT rezendeizabelamauricio laterelapsinghepatitisafteryellowfever AT pereiraleonardosoares laterelapsinghepatitisafteryellowfever AT fradicojordanarodriguesbarbosa laterelapsinghepatitisafteryellowfever AT pascoalxaviermarceloantonio laterelapsinghepatitisafteryellowfever AT alvespedroaugusto laterelapsinghepatitisafteryellowfever AT campiazevedoanacarolina laterelapsinghepatitisafteryellowfever AT spezialielaine laterelapsinghepatitisafteryellowfever AT dossantosliviazignagomoreira laterelapsinghepatitisafteryellowfever AT albuquerquenataliasoares laterelapsinghepatitisafteryellowfever AT penidoindiara laterelapsinghepatitisafteryellowfever AT santostayrinearaujo laterelapsinghepatitisafteryellowfever AT bomanapauladinisano laterelapsinghepatitisafteryellowfever AT dasilvaandreamarquesvieira laterelapsinghepatitisafteryellowfever AT fernandescamillabayma laterelapsinghepatitisafteryellowfever AT calzavaracarloseduardo laterelapsinghepatitisafteryellowfever AT kroonernageessien laterelapsinghepatitisafteryellowfever AT martinsfilhoolindoassis laterelapsinghepatitisafteryellowfever AT teixeiracarvalhoandrea laterelapsinghepatitisafteryellowfever AT drumondbetaniapaiva laterelapsinghepatitisafteryellowfever |